Artiva Highlights Durable AlloNK Outcomes at 2026 Tandem
San Diego, California, January 21, 2026 — Artiva Biotherapeutics, a clinical-stage biopharmaceutical company focused on allogeneic natural killer (AlloNK)...
Cell Therapy
Advertisement
FibroBiologics to Present at Global Healthcare Investment Forum
HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...
Omisirge Delivers Breakthrough Outcomes for Severe Aplastic Anemia
DUBLIN, IRELAND & LONDON, UK — December 8, 2025 — Ayrmid Ltd., parent company of Gamida Cell Inc., announced...
NKGen Biotech Issues Statement on New Board Appointments at NKGen Korea
Santa Ana, California, December 3, 2025 — NKGen Biotech has issued an official statement regarding new board appointments at...
Aspen Neuroscience Secures $115M to Advance Cell Therapy
SAN DIEGO, CA — November 20, 2025 — Aspen Neuroscience, a leading developer of personalized autologous cell therapies for...
Advertisements
ACP-01 Cell Therapy Moves Into Trial for Vascular Dementia
Calgary, Alberta — November 20, 2025 — Hemostemix Inc. announced that Dr. William R. Shankle, MS, MD, FACP, a...
Adaptimmune Restructures Leadership to Advance Cell Therapy Strategy
Dateline: November 17, 2025 — Philadelphia, PA & Oxford, UKAdaptimmune Therapeutics plc announced significant Board and Executive Leadership changes,...
IN8bio Reports Strong Q3 Progress in Gamma-Delta T Cell R&D
NEW YORK, November 6, 2025 — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing gamma-delta (γδ) T cell...
FDA Grants RMAT Designation to Avobis Bio’s AVB-114 for Crohn’s Perianal Fistulas
Newark, Del., October 3, 2025 – Avobis Bio LLC, a clinical-stage biotechnology company focused on implantable cell therapies, announced...
Avant and Austrianova Launch JV for Klotho Cell Therapies
September 18, 2025 — Las Vegas, Nevada Avant Technologies and Austrianova have entered into a Joint Venture and Licensing...
Advertisement
